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http://dxObjectives: Radial artery (RA) grafting has a clear survival advantage after coronary artery bypass grafting
(CABG) in studies with predominantly male populations, but the impact on women’s long-term survival is un-
clear. We sought to determine if the reported long-term survival benefit of RAversus saphenous vein (SV) graft-
ing in the general CABG population is valid for women.
Methods: Between 1995 and 2010, 1339 female patients were alive 30 days after primary, isolated CABG with
left internal thoracic artery (LITA) and additional RA or SV conduits as needed. Patients were evaluated based
on RA use: 332 patients had RA and 1007 patients had SV. Of these, 283 RA patients were matched to SV coun-
terparts using a nonparsimonious propensity model based on 45 patient variables.
Results:Kaplan-Meier estimated survivals for the matched RAwomen at 1, 5, 10, and 15 years were 99%, 93%,
80%, and 70% versus 97%, 87%, 72%, and 58% for the SV women (log rank, P ¼ .018). For symptomatic
patients, overall RA patency was 80%, which was not different from the LITA patency rate of 84% but was
superior to the SV conduits patency rate of 56% (P<.001).
Conclusions: In women undergoing CABG with LITA grafting, use of an RA graft improves survival compared
with use of an SV graft. (J Thorac Cardiovasc Surg 2013;146:1467-73)A
C
DWomen have been reported to have increased hospital
mortality and morbidity after coronary artery bypass
grafting (CABG), in part attributed to referral bias,
smaller coronary vessels, smaller body size, more ad-
vanced coronary artery disease, older age at presentation,
markedly higher risk profile, higher transfusion rate, gen-
der differences in molecular remodeling in pressure over-
load hypertrophy, and a higher incidence of metabolic
syndrome.1 However, intermediate and long-term sur-
vivals have been reported to be better in women and the
use of 2 or more arterial grafts in women is associated
with improved long-term survival.2 Thus, the addition of
a second arterial conduit may be an important determinate
of survival in women after CABG.
Use of a radial artery (RA) conduit in addition to the left
internal thoracic artery (LITA) improves patients’ long-
term survival after CABG.3-7 In these reports, however,
only 10% to 23% of the study populations were women,
and it is unclear whether, and to what extent, this
observed RA survival benefit extends to women. In
our previous report,3 we were not able to show a survival
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The Journal of Thoracic and Cara secondary analysis. However, women comprised only
17% of our patients and there were very few patients at
risk after 8 years. Thus, in this study, we specifically sought
to determine the effect of RA grafting on long-term survival
after CABG in women by comparing propensity-matched
women revascularized with LITA and RAversus women re-
ceiving LITA and only saphenous vein (SV) grafts.METHODS
Patients
From January 1995 to December 2010, 1367 women had isolated, pri-
mary CABG with LITA and additional grafts as needed after excluding
patients with single CABG (n ¼ 4), only SV grafts (n ¼ 8), or only bilat-
eral internal thoracic artery (BITA) grafts (n ¼ 9). At 30 days, 1339
women were alive and were included in the analysis. Of these, 332 pa-
tients received an RA conduit (RA group), and 1007 received SV con-
duits. The primary factors involved in the decision to use an RA
conduit included the result of the Allen test, perceived patient lifespan
(patients<65 years), nonemergency nature of the operation, and a target
vessel stenosis of at least 70%. Unavailable or unsuitable SV conduits ac-
counted for RA use in older patients. Most RA grafts were used to bypass
the circumflex (73%) and diagonal (21%) arteries. Only 6% received an
RA to the right coronary artery. Renal failure was considered a contraindi-
cation for RA harvest owing to concern for the need for possible upper
limb dialysis access.
All data were prospectively collected as part of the New York State De-
partment of Health mandatory reporting system and maintained in a sepa-
rate database at our institution. Institutional review board approval was
obtained and written informed consent was waived.
Graft Patency
The New York State Department of Health Cardiac Surgery Reporting
System and the Percutaneous Coronary Intervention Reporting System da-
tabases were used to identify patients who had undergone coronary reinter-
vention after CABG in our institution. Symptom driven after CABG
angiograms was identified and analyzed by 2 observers independently.diovascular Surgery c Volume 146, Number 6 1467
Abbreviations and Acronyms
BITA ¼ bilateral internal thoracic artery
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
HR ¼ hazard ratio
LITA ¼ left internal thoracic artery
RA ¼ radial artery
SV ¼ saphenous vein
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DSurgical Technique
CABG was mostly performed using cold blood cardioplegic arrest and
a single period of aortic crossclamping. RAs were used as aorta–coronary
bypasses and sequential or Y grafts. Off-pump procedures were performed
in 2.5% of all patients (2.6% of the SV patients and 0.9% of the RA pa-
tients) generally owing to an unclampable or heavily diseased ascending
aorta. None of the propensity-matched patients had off-pump surgery. Be-
fore 1999, the RAwas harvested using an open no-touch technique; since
2000, all RA conduits in our institution have been harvested exclusively us-
ing an endoscopic technique. The RA is readily harvested endoscopically
via a small wrist incision.8 It is 15 to 25 cm long, easily reaches any vessel
on the heart, and is a better size match to the native coronary arteries than is
the SV. Sequential or Y grafting increases the number of arterial grafts per
patient. Diltiazem is administered by intravenous infusion after induction
of anesthesia and is continued until the first postoperative day, when oral
nitrates or diltiazem is substituted and continued wherever possible for at
least 6 months. Intraoperative Allen test and pulse oximetry were used to
confirm adequate collateral blood flow to the hand. Less than 2% of
screened RAs could not be harvested. No postoperative hand ischemia
has been detected. A rare harvested RA had to be discarded because of un-
suspected severe wall thickening or calcific disease. After division, the RA
was cannulated at the proximal end and placed in a solution of 1% papav-
erine mixed with the patient’s heparinized venous blood, which contains
diltiazem.
Statistical Methods
All available risk factors (Table 1) were included in a nonparsimonious
multivariable logistic regression model that predicted the probability of
treatment with the RA rather than the SV conduit.9 On the basis of the num-
ber of grafts used for CABG, the year of CABG, and the value of the pro-
pensity score as a composite variable, RA patients were matched to SV
patients using the nearest neighbor matching method. We compared the
balance of all baseline characteristics in Table 1 before and after the match-
ing using the standardized difference. Our model was well calibrated and
discriminated effectively between RA and non-RA patients at baseline
(c-statistic ¼ 0.821). Patients on hemodialysis and with a creatinine level
greater than 2.5 mg/dL (53 in the SV group and 3 in the RA) were excluded
from the matching process.
Statistical analysis was performed with the Zelig/CRAN 2.14.01 (http://
cran.r-project.org)10 and XLSTAT software. Continuous variables were
expressed as mean and standard deviation. Categorical variables were ex-
pressed as numbers and percentages. Dichotomous variables were analyzed
using the c2 test and Fisher’s exact test, and continuous variables were an-
alyzed using the t test. The primary end point was all-cause mortality ob-
tained using the Social Security Death Index, which was searched in May
2011. The overall difference in survival between RA and SV patients was
estimated by comparing the Kaplan-Meier survival curves for the matched
patients. The overall hazard ratios (HR) for death after CABG were ob-
tained by fitting a Cox proportional hazards model, stratifying on the
matched pairs of patients. Inasmuch as CABG is a factor influencing early1468 The Journal of Thoracic and Cardiovascular Surdeath, the patients who died in the hospital or within 30 days after CABG
were excluded from the matching and survival analysis.
Statistical analysis of graft patency was performed with STATA system
version 12.1 (StataCorp LP, College Station, Tex). The primary end point
was graft failure, defined as graft occlusion or a 50% stenosis or greater.
The Cox proportional hazard model was used to assess differences in the
HR between groups defined by graft type. Because patients contributed 1
or more grafts to the analysis, robust standard errors and confidence limits
for the HRs were achieved by adjusting for 244 female patients’ clusters
within the data.RESULTS
Demographic Characteristics
Table 1 shows that unmatched RAwomen (n¼ 332) com-
pared with SV women (n ¼ 1035) were younger (average
age, 59.5 years vs 70 years), more obese (body mass index,
29.7 vs 27.7; body surface area, 1.83 vs 1.77), had higher
ejection fractions (average, 54% vs 50%), and fewer cases
of preoperative myocardial infarction, chronic obstructive
pulmonary disease, peripheral vascular disease, stroke, hy-
pertension, and congestive heart failure (Table 1). Also, RA
women were more likely to have diabetes (53% vs 47.5%),
receive more grafts (average, 3.6 vs 3.4), and have longer
crossclamp and bypass times.
Propensity matching yielded 283 pairs of women revas-
cularized with either an RA or an SV. The propensity match-
ing model was well calibrated. Table 1 shows that the
standardized differences in the prevalence of all baseline
characteristics between RA and SV women were all less
than or equal to 2% and were not statistically different.Hospital Outcomes
There were no hospital and 30-day deaths in the un-
matched RA group and 28 (2.7%) deaths in the SV group
(P<.0001). These hospital and early deaths were excluded
from the propensity matching model and survival analysis.
Table 1 shows that in the matched patients, rates of postop-
erative stroke, postoperative myocardial infarction, renal
failure, and sternal wound infection were similar. There
was a trend toward a higher incidence of respiratory failure
in the SV group compared with the RA group (P ¼ .06).Long-Term Survival
During the follow-up period, 70 (25%) deaths were
observed among the 283 matched SV patients and 48
(17%) deaths among the 283 matched RA patients
(P ¼ .023). Figure 1 shows that the Kaplan-Meier esti-
mated survivals for the matched RA women at 1, 5, 10,
and 15 years were 99% (confidence interval [CI], 98%-
100%), 93% (CI, 96%-98%), 80% (CI, 72%-87%),
and 70% (CI, 60%-79%) versus 97% (CI, 96%-100%),
87% (CI, 82%-92%), 72% (CI, 63%-80%), and 58%
(CI, 38%-65%) for the SV women (log rank, P ¼ .018).
The average survival time for the RA female patients af-
ter CABG was 13  0.3 years (range, 12.2-13.8 years) andgery c December 2013
TABLE 1. Patients’ baseline, operative, and postoperative characteristics
RA patients (n ¼ 332) SV patients (n ¼ 1035) P
Matched RA
patients (283)
Matched SV
patients (283) P
Propensity score 0.457 (0.23) 0.191 (0.18) <.0001 0.409 (0.17) 0.399 (0.15) .808
Age (y) average 59.5 (9.1) 70 (9.2) <.0001 61 (8.6) 61 (8.8) .841
<50 y (patients,%) 43 (13%) 28 (2.7%) <.0001 24 (8.5%) 24 (8.5%) 1.000
50-59 y (patients,%) 123 (37%) 112 (4%) <.0001 99 (35%) 97 (34%) .802
60-69 y (patients,%) 125 (38%) 354 (35%) .252 120 (42%) 122 (43%) .810
70 y (patients,%) 41 (12.3%) 541 (52%) <.0001 40 (14%) 40 (14%) 1.000
BMI 29.7 (6.1) 27.7 (6.4) <.0001 30.1 (6.2) 29.3 (6.2) .174
BSA 1.83 (2.22) 1.77 (2.20) <.0001 1.83 (2.22) 1.81 (2.22) .293
Ejection fraction average 54 (11.4) 50 (12.3) .011 50 (11.5) 50 (12.0) .744
<20% 5 (1.5%) 19 (1.8%) .691 4 (1.4%) 1 (0.3%) .178
20%-29% 9 (2.7%) 34 (13.3%) .602 8 (2.8%) 9 (3.2%) .806
30%-39% 33 (10%) 133 (13%) .158 30 (11%) 35 (12%) .501
40%-49% 57 (17%) 220 (21%) .107 57 (20%) 57 (20%) 1.000
50% 219 (66%) 589 (57%) .003 184 (65%) 180 (64%) .701
Missing 9 (2.7%) 40 (3.9%) .325 0.000 0.000
No. of grafts 3.6 (0.908) 3.4 (0.864) .006 3.5 (0.9) 3.5 (0.9) 1.000
Years since surgery 7.35 (4.5) 7.6 (4.1) .256 7.2 (4.5) 7.2 (4.5) 1.000
Ethnicity/race
Nonhispanic white 130 (40%) 425 (41%) .952 110 (39%) 112 (40%) .695
Nonhispanic black 63 (19%) 217 (21%) .435 59 (21%) 61 (21.5%) .803
Hispanic 111 (33%) 331 (32%) .480 93 (33%) 90 (32%) .788
Other 28 (8%) 62 (6%) .433 21 (7.4%) 20 (7%) .820
Priority
Elective 70 (21%) 192 (19%) .308 60 (21%) 60 (21%) 1.000
Urgent 232 (70%) 757 (73%) .504 200 (71%) 200 (71%) 1.000
Emergency 30 (9%) 86 (8%) .700 23 (8%) 23 (8%) 1.000
CCS (%)
Class I 2 (0.6%) 13 (4%) .320 1 (0.4%) 5 (1.8%) .101
Class II 13 (4%) 29 (2.8%) .307 8 (2.8%) 10 (3.5%) .633
Class III 111 (33%) 279 (27%) .023 89 (31%) 85 (30%) .710
Class IV 206 (62%) 714 (69%) .019 185 (65%) 183 (65%) .886
Diseased vessels
Isolated LMT 5 (1.5%) 20 (1.95%) .614 4 (1.4%) 4 (1.4%) 1.000
TVD þ LMT 63 (19%) 208 (20%) .656 55 (19%) 51 (18%) .517
TVD no LMT 222 (67%) 665 (64%) .385 150 (53%) 151 (53%) .864
DVD þ LMT 15 (4.5%) 92 (8.9%) .010 31 (11%) 33 (12%) .736
DVD no LMT 47 (14.2%) 162 (15.2%) .510 42 (15%) 44 (15.5%) .732
Proximal LAD 240 (72%) 750 (72%) .815 199 (70%) 203 (72%) .664
Mid/distal LAD 230 (69%) 636 (61%) .064 192 (68%) 188 (66%) .432
RCA or PDA 292 (88%) 867 (84%) .076 247 (87%) 245 (86%) .897
Circumflex or OM 275 (83%) 849 (82%) .771 231 (82%) 234 (83%) .858
Previous MI 135 (41%) 517 (50%) .003 116 (41%) 119 (42%) .798
1-7 d previously 26 (7.8%) 91 (8.8%) .586 20 (7%) 20 (7%) 1.000
8-14 d previously 21 (6.3%) 92 (8.9%) .140 19 (6.7%) 20 (7%) .850
15-20 d previously 2 (0.6%) 19 (1.8%) .112 2 (0.07%) 4 (1.4%) .789
21 d previously 86 (26%) 315 (30.4%) .115 75 (26.5%) 75 (26.5%) 1.000
Stroke 22 (6.7%) 100 (9.7%) .092 21 (7.4%) 23 (8%) .754
Carotid disease 35 (10.5%) 172 (16.6%) .007 33 (11.7%) 32 (11%) .895
Aortoiliac PVD 6 (1.8%) 37 (3.6%) .109 5 (1.8%) 4 (1.4%) .737
Femoropopliteal PVD 31 (9.3%) 94 (9.1%) .888 27 (9.5%) 27 (9.5%) 1.000
Unstable hemodynamics 3 (1%) 15 (1.5%) .448 2 (0.7%) 5 (1.8%) .255
Hypertension 241 (73%) 839 (81%) .001 214 (76%) 214 (76%) 1.000
On IV NTG before CABG 24 (7.2%) 168 (16%) <.0001 20 (7%) 17 (6%) .611
Current CHF 28 (8.4%) 200 (19.3%) <.0001 27 (10%) 32 (11%) .687
(Continued)
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TABLE 1. Continued
RA patients (n ¼ 332) SV patients (n ¼ 1035) P
Matched RA
patients (283)
Matched SV
patients (283) P
COPD 85 (25.6%) 391 (37.8%) <.0001 77 (27.2%) 77 (27.2%) 1.000
Ascending aorta atherosclerosis 8 (2.4%) 88 (8.5%) <.001 7 (2.4%) 11 (4%) 1.000
Diabetes 176 (53%) 492 (47.5%) .083 151 (53%) 155 (55%) .736
PCI before 49 (15%) 137 (13.2%) .482 37 (13%) 50 (18%) .130
No renal failure* 329 (99%) 982 (95%) .001 283 (100%) 283 (100%) 1.000
Crossclamp time (min) 70 (21.3) 60 (20.5) <.0001 68 (21.1) 61 (21.1) <.001
CPB time (min) 92 (27) 83 (31) <.0001 91 (26.8) 85 (28.1) .009
Thirty-day postoperative complications
Permanent stroke 2 (0.6%) 13 (1.3%) .320 2 (0.7%) 1 (0.4%) .563
Postoperative MI 3 (1%) 13 (1.3%) .604 3 (1%) 5 (1.8%) .477
Sternal wound infection 8 (2.4%) 20 (1.9%) .594 7 (2.5%) 3 (1%) .203
Reoperation for bleeding 3 (1%) 17 (1.6%) .330 2 (0.7%) 4 (1.4%) .413
Septicemia 6 (1.8%) 27 (2.6%) .408 5 (1.8%) 2 (0.7%) .255
Renal Failure 4 (1.2%) 30 (2.9%) .085 3 (1%) 4 (1.4%) .704
Respiratory failure 7 (2.1%) 63 (6.1%) .004 7 (2.5%) 16 (5.7%) .056
Angiography after CABG 67 (20.2%) 177 (17%) .218 52 (18.4%) 75 (26.5%) .020
Hospital and 30-d mortality 0.000 28 (2.7%) <.0001 — — 1.000
All-cause mortality 54 (16.3%) 369 (35.7%) <.0001 48 (16.9%) 70 (24.9%) .023
RA, Radial artery; SV, saphenous vein; BMI, body mass index; BSA, body surface area; CCS, Canadian Cardiovascular Society functional class; LMT, left main trunk; TVD, triple
vessel disease;DVD, doublevessel disease;LAD, left anterior descending artery;RCA, right coronary artery;PDA, posterior descendingartery;MI,myocardial infarction;OM, obtuse
marginal artery; PVD, peripheral vascular disease; IV, intravenous; NTG, nitroglycerin; CABG, coronary artery bypass grafting; CHF, chronic heart failure; COPD, chronic
obstructive pulmonary disease; PCI, percutaneous intervention; CPB, cardiopulmonary bypass. *Renal failure: hemodialysis and with creatinine level greater than 2.5 mg/dL.
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Dfor the SV patients, 11.5 0.3 years (range, 10.5-12 years).
The difference in the survivals between RA and SV women
was 6% at 5 years (P ¼ .024), 12% at 10 years (P ¼ .022),
and 22% at 15 years (P ¼ .01).
Table 2 shows that independent risk factors for death
after CABG are older age, diabetes, congestive heart
failure, ascending aorta atherosclerosis, and chronicFIGURE 1. Comparison of 0- to 15-year Kaplan-Meier survival data in 566 pro
artery (RA) coronary artery bypass grafting (CABG) versus LITA/saphenous ve
fixed time points with the corresponding P values.
1470 The Journal of Thoracic and Cardiovascular Surobstructive pulmonary disease. The propensity score
was included in the multivariate Cox proportional regres-
sion model to adjust for selection bias and was not found
to be an independent predictor for death (P ¼ .6). Use
of the RA exhibited a strong protective effect on the
long-term survival with an HR of 0.64 (CI, 0.44-0.90;
P ¼ .017).pensity-matched women receiving left internal thoracic artery (LITA)/radial
in (SV) CABG. Inserted table provides the patient at risk in each group at
gery c December 2013
TABLE 2. Multivariate Cox proportional regressionmodel of HRs for
death in women after CABG
Variable HR
Lower CI
(95%)
Upper CI
(95%)
P
value
Age (y) 1.11 1.06 1.17 <.0001
CHF 2.71 1.63 4.50 <.0001
COPD 1.84 1.28 2.65 .001
Diabetes 1.80 1.22 2.63 .003
Ascending aorta atherosclerosis 3.26 1.50 7.07 .003
Radial artery 0.64 0.44 0.90 .017
HR, Hazard ratio; CABG, coronary artery bypass grafting; CI, confidence interval;
CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease.
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Of the total cohort of 1367 female patients, 244 (67
[20%] in the RA group and 177 [17%] patients in the SV
group) had symptom-driven cardiac catheterization at our
institution 0.1 to 15 years after CABG. The mean time to
catheterization was 6  3.6 years, with a median of 5.8
years. Table 3 shows angiographic patency per distal anas-
tomosis for all conduits. Overall patency for LITA, RA, and
SV grafts was 84%, 80%, and 56%, respectively. Of the 86
RA conduits, 76 were grafted to the circumflex territory, 5
to the diagonal branches of the left anterior descending cor-
onary artery, and 5 to the right coronary artery. Of the 500
SV conduits, 200 were grafted to the circumflex, 104 to
the diagonals, and 196 to the right coronary artery.
Of the 67 studied RA patients, 43 had endoscopic and 24
had open harvest of the RA. The overall RA patency was
85% (46 of 54 grafts) for the endoscopically harvested
RA, which was not different from the overall patency of
72% (23 of 32 grafts) for the patients with open harvest
of the RA (P ¼ .1).
Figure 2 shows the patency for LITA, RA, and SV grafts.
Cox modeling showed that both LITA (HR ¼ 0.33, 95%
CI ¼ 0.24-0.46; P< .0001) and RA (HR ¼ 0.38, 95%
CI ¼ 0.22-0.64; P< .0001) graft patencies were signifi-
cantly better than SV patency. LITA and RA patency rates
were similar.
DISCUSSION
The most important finding in this study is that the
women who received 2 arterial conduits, the LITA and
RA, had a significant survival benefit 15 years after
CABG compared with women revascularized withTABLE 3. Patency of LITA, RA, and SV conduits in 244 symptomatic
patients after CABG
Conduits Perfectly patent Occluded or stenotic
LITA (n ¼ 245) 207/245 (84%) 38/245 (16%)
RA (n ¼ 86) 69/86 (80%) 17/86 (20%)
SV (n ¼ 500) 279/500 (56%) 221/500 (44%)
LITA, Left internal thoracic artery; RA, radial artery; SV, saphenous vein graft;
CABG, coronary artery bypass grafting.
The Journal of Thoracic and Carthe LITA and only SV. CABG with LITA/RA results in
a 36% decrease in all-cause 15-year mortality compared
with traditional LITA/SV CABG in women (Table 2). Use
of the RA was an independent and highly significant
(P ¼ .017) predictor of improved survival in the
propensity-matched groups. Women had a 12% higher
rate of survival 10 years after CABG and a 22% higher sur-
vival at 15 years after CABG using RA conduit compared
with only SV graft (log rank, P ¼ .018; Figure 1).
The use of at least 1 internal thoracic artery improves
both in-hospital and long-term results after CABG,11 yet
LITA use in women is only 50% to 75%,12 significantly
less than the 80% to 95% LITA use in men. The Society
of Thoracic Surgeons National Cardiac Database13 identi-
fied female gender as an independent predictor for the non-
use of an internal thoracic artery graft. Ahmed and
colleagues14 examined early and long-term results in 1114
women and 3628 men after CABG. Their adjusted hazard
models for long-term all-cause mortality showed that use
of the LITA and revascularization with more than 3 distal
anastomoses has a protective effect on women’s survival.
Guru and colleagues15 showed that multiarterial grafting
is associated with better long-term results in women. Yet,
the use of BITA grafts in women is an infrequent occur-
rence. In the 4 major reports of the survival benefits of
BITA grafting, women represented only 9% to 15%
of the BITA patient population.11,16-18 Thus, only 50% to
75% of women receive a LITA and very few women
receive more than 1 arterial conduit during CABG.
BITA grafting, especially in diabetic, obese female pa-
tients, increases the risk of sternal infection. Osteoporosis
in middle-aged and elderly women may lead to sternal de-
hiscence, which further strongly discourages the use of
BITA in women. In addition, smaller vessels in women
have been suggested as a reason to avoid arterial conduit
use, but there is little evidence to substantiate that position.
In fact, it has been shown that LITA size is approximately
equal in men and women, and women are no more likely
than men to have native coronary vessels less than 1.5
mm in diameter.19 Surgeons have hesitated to use the RA
in women owing to the fear of smaller RA caliber and
spasm. In our experience, the RA is a very good size match
for women’s coronary vessels and RA grafts are frequently
needed in patients with varicose veins. Perioperative RA
spasm is rare and easily avoided with strict postoperative
protocol treatment with oral nitrates and calcium-channel
blockers, along with precise and injury-free endoscopic har-
vesting of the RA.8
Our overall RA patency in symptomatic post-CABG fe-
male patients was 80% consistent with the results pub-
lished by others20,21 and our previous report of 81% in
combined male and female patients. In contrast to
our results, Khot and colleagues22 found an overall RA pa-
tency rate of 51% and specifically an RA patency rate ofdiovascular Surgery c Volume 146, Number 6 1471
FIGURE 2. Graft patency from Coxmodeling adjusting for patient clusters. LITA, Left internal thoracic artery; RA, radial artery; SV, saphenous vein grafts;
CABG, coronary artery bypass grafting.
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Donly 39% in women; they concluded that the female gender
is a significant predictor for RA occlusion. However, their
study included a very small number of women (17%)
and had a large number (22%) of patients undergoing
redo operations mixed with patients undergoing primary
CABG.
The current results from ongoing randomized trials, in-
cluding the Radial Artery Versus Saphenous Vein Patency
(RSVP), the Radial Artery Patency Study (RAPS), and the
Radial Artery Patency and Clinical Outcomes (RAPCO),
all confirm excellent patency rates (85%-98%) of RA
grafts for both genders at 1, 5, and 10 years.23 Desai
and associates24 found that RA conduits had a significantly
lower occlusion rate than SV grafts at 1 year, and this ef-
fect was especially strong in women. Lawton and col-
leagues25 found that, compared with SV graft recipients,
women who received RA grafts had significantly im-
proved 5-year survival, but patency rates were not re-
ported. Our findings suggest that RA patency is similar
to LITA patency and that RA patency is better than SV pa-
tency in women. This improved RA patency likely results
in improved long-term survival in women undergoing
CABG.Limitations
This is an observational study, but the series represents
a large, single-site, consecutive experience with standard-
ized techniques. Preoperative, operative, and in-hospital
postoperative data are derived from a mandatory, audited
state database and recorded prospectively. Only patients
with isolated primary CABG were analyzed. Survival data1472 The Journal of Thoracic and Cardiovascular Surare derived from the Social Security Death Index and not
from individual patient follow-up. Coronary angiography
after surgery was not protocol driven, and we were able to
capture only those patients who returned to our hospital
for the angiogram. More RA grafts were used in patients
who were younger, had no current dialysis requirement,
with higher left ventricular ejection fraction, no congestive
heart failure, no chronic obstructive pulmonary disease,
elective surgery, and no calcified ascending aorta. The dis-
crepant comorbid profiles were adjusted by using propen-
sity matching.SUMMARY
We have found that women who received 2 arterial con-
duits, LITA and RA, had a significant survival benefit
15 years after CABG compared with women revascularized
with LITA and only SV. LITA/RA CABG results in a 36%
decrease in risk-adjusted 15-year mortality compared with
traditional LITA/SV CABG (Table 3). Use of the RA was
an independent and highly significant (P ¼ .017) predictor
of improved survival for women in the propensity-matched
groups. RA patency is similar to LITA patency and better
than SV patency, which likely results in the improved
long-term survival.CONCLUSIONS
Long-term survival after CABG in women is substan-
tially improved with the use of the RA when the LITA
is used to bypass the left anterior descending coronary ar-
tery. RA grafting in women should be more frequently
used.gery c December 2013
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